ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 686513 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 686513; 2) Community: the network communities that were significantly associated with the response to NSC 686513; 3) Molecule: the relationships between components within communities and NSC 686513; 4) MDR: the compounds that were significantly associated with the NSC 686513.

NSC Compound Enrichment Correlation
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.0137568419586474 0.34847586
NSC 758682 ARTENIMOL 0.0137568419586474 0.36395448
NSC 761834 (Z)-5-chloro-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.0137568419586474 0.25773328
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.0137568419586476 0.45969585
NSC 180973 Tamoxifen citrate 0.0137568419586476 0.25447185
NSC 308847 Amonafide 0.0137568419586476 0.50034756
NSC 329691 HM-4 0.0137568419586476 0.3536487
NSC 382035 2,4-Pyrimidinediamine, 6-ethyl-5-[4-[methyl(phenylmethyl) amino]-3-nitrophenyl]- 0.0137568419586476 0.62449579
NSC 382049 2,4-Pyrimidinediamine, 6-ethyl-5-[3-nitro- 4-[(2-phenylethyl)amino]phenyl]- 0.0137568419586476 0.67913789
NSC 620687 Null 0.0137568419586476 0.34209526
Total:91  Current:29    [First] [Prev] [Next] [Last]